Next Article in Journal
A 10-Year Retrospective Study on Pediatric Visceral Leishmaniasis in a European Endemic Area: Diagnostic and Short-Course Therapeutic Strategies
Previous Article in Journal
Musculoskeletal, Functional and Performance Impairment in Female Overhead Athletes with a Previous Shoulder Injury
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Understanding the Causes of Frailty Using a Life-Course Perspective: A Systematic Review

by
Antonio Barrera
1,
Leandro F. M. Rezende
2,
Angelo Sabag
3,
Christopher J. Keating
4 and
Juan Pablo Rey-Lopez
1,4,*
1
Faculty of Health Sciences, Universidad Internacional de Valencia (VIU), 46002 Valencia, Spain
2
Department of Preventive Medicine, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo 04023-900, SP, Brazil
3
Discipline of Exercise and Sport Science, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia
4
Facultad de Deporte, UCAM Universidad Catolica de Murcia, 30107 Murcia, Spain
*
Author to whom correspondence should be addressed.
Healthcare 2024, 12(1), 22; https://doi.org/10.3390/healthcare12010022 (registering DOI)
Submission received: 29 November 2023 / Revised: 16 December 2023 / Accepted: 18 December 2023 / Published: 21 December 2023
(This article belongs to the Section Preventive Medicine)

Abstract

:
(1) Background: Few studies have examined risk factors of frailty during early life and mid-adulthood, which may be critical to prevent frailty and/or postpone it. The aim was to identify early life and adulthood risk factors associated with frailty. (2) Methods: A systematic review of cohort studies (of at least 10 years of follow-up), using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA). A risk of confounding score was created by the authors for risk of bias assessment. Three databases were searched from inception until 1 January 2023 (Web of Science, Embase, PubMed). Inclusion criteria were any cohort study that evaluated associations between any risk factor and frailty. (3) Results: Overall, a total of 5765 articles were identified, with 33 meeting the inclusion criteria. Of the included studies, only 16 were categorized as having a low risk of confounding due to pre-existing diseases. The long-term risk of frailty was lower among individuals who were normal weight, physically active, consumed fruits and vegetables regularly, and refrained from tobacco smoking, excessive alcohol intake, and regular consumption of sugar or artificially sweetened drinks. (4) Conclusions: Frailty in older adults might be prevented or postponed with behaviors related to ideal cardiovascular health.

1. Introduction

Numerous potential biomarkers of aging have been proposed in the scientific literature, including molecular, imaging, and clinical data [1]. Frailty is a composite aging biomarker characterized by a condition of decreased physiological reserve that leads to a vulnerable state and increases the risk of adverse health outcomes when exposed to a stressor [1]. In 2001, two definitions of frailty were introduced in the geriatric literature (although more definitions can be found in the scientific literature). The phenotypic model of Fried et al. [2] is based on the presence of three (or more) of the following characteristics: (a) an involuntary weight loss, (b) self-reported exhaustion in daily life activities, (c) a low level of physical activity, (d) habitual slow walking speed, and (e) muscular weakness. Another frailty definition is the accumulation of deficits model (or frailty index) of Mitnitski et al. [3], which includes deficiencies of functional, sensory, and clinical nature. In a recent systematic review, the prevalence of frailty in older adults in 62 countries and territories was 12% (Fried phenotype) or 24% (frailty index) [4]. Women and individuals of a low socioeconomic status level are more likely to become frail, according to a narrative review of Taylor et al. [5]. Frailty remains an important public health problem because frail individuals (versus non-frail) are at higher risk of physical disability [2], falls [6], fractures [7], hospitalizations [8], institutionalization [9], and death [10].
In a recent systematic review of older adults (at least 65 years old) [11], authors identified a large number of lifestyle factors and characteristics associated with frailty. Information was mainly derived from cross-sectional studies or cohort studies with a short follow-up. However, it is well established that a life-course perspective offers a more suitable approach to understanding how the aging processes and their consequences emerge during the lifetime [12]. Lowering the accumulation of harmful exposures throughout the life course or changing unhealthy behaviors during adulthood may lead to more favorable trajectories of aging [12]. However, many statistical associations found in observational studies of risk factors of frailty could reflect bias (reverse causality, selection bias, and measurement errors), confounding, or chance [13]. To reduce the risk of bias due to pre-existing diseases in the synthesis of evidence, some epidemiologists recommend following some analytical approaches [14], such as (1) excluding (or adjusting for) participants with major noncommunicable diseases (NCDs) at baseline (CVDs, stroke, cancer, and respiratory diseases); (2) including only cohort studies with a minimum of 10 years of follow-up in meta-analysis; and (3) excluding death cases occurring in the first 5 years of follow-up.
To sum up, to the best of our knowledge, no systematic review until now has evaluated how early-life and middle-life risk factors are associated with frailty or studied their epidemiological validity using risk of bias assessments. The main objective of this systematic review was to identify early- and middle-life risk factors associated with frailty in older adults. We also aimed to examine whether authors included appropriate analytical methods to deal with confounding due to pre-existing diseases.

2. Materials and Methods

2.1. Literature Search and Screening

To formulate a clear and concise research question, a description of the population, intervention/exposure, comparison, and outcomes are provided. We searched cohort studies that examined associations between any risk factor (Exposure) during adulthood, adolescence, childhood, or natal factors (Population) associated with frailty (Outcome), using Web of Science, Embase, and PubMed (from inception until 1 January 2023). One researcher (A.S.) was in charge of producing the first database for the identification of relevant scientific literature. Details of the list of keywords are included in Table S1. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines to report the results of this systematic review [15]. Two authors, A.B. and J.P.R.-L., screened independently articles by title and abstract and, in a later stage, reading full-text articles using the website covidence.org In case of discrepancies, a third author (C.J.K.) made a final decision.
The eligibility criteria of this systematic review were any cohort study in humans (both sexes, healthy at baseline), published in English language, that evaluated associations of risk factors associated with frailty status in humans. Studies with a retrospective study design were eligible studies, as they inform about early-in-life risk factors. In addition, we considered eligible those studies cited in references from selected studies. Exclusion criteria: studies whose cohort studies had a follow-up lower than 10 years were excluded because they did not inform of early- or middle-life risk factors. Studies published in non-English language or abstracts of conferences were excluded.

2.2. Data Extraction

We retrieved the first author’s name, year of publication, country, sample size, participant’s sex, age at baseline, exposure variable/s, frailty definition, average length of follow-up, and fully adjusted hazard ratio (HR) or odds ratio (OR) or relative risk ratio (RR) and 95% confidence intervals (CIs) for frailty, comparing for each exposure variable (using 1-unit increase or comparations between categories with the highest and lowest values; Comparison). We also extracted data about the covariates used in the fully adjusted model and whether authors included sensitivity analyses in their publications. Data extraction was performed by one researcher (A.B.) and double-checked by another (J.P.R.-L.).

2.3. Risk of Confounding Due to Pre-Existing Diseases

Three methodological characteristics defined the risk of confounding based on subject matter expertise instead of a mechanistic risk of bias assessment [16]: average age at baseline of 70+ years, authors did not exclude participants with diseases/conditions at baseline and did not adjust for diseases/conditions in the fully adjusted model. A risk of confounding score was created with the three mentioned characteristics (ranging from zero to three). We defined a high risk of confounding due to pre-existing diseases when studies had two or three points in the confounding score (total of three). Scores were calculated by one senior researcher (J.P.R.-L.) with prior experience in risk-of-bias assessments of epidemiological studies. A comprehensive meta-analysis of each risk factor identified was initially planned, taking into account the risk of confounding scores, but it was finally discarded due to the scarce number of studies identified.

3. Results

Figure 1 shows the PRISMA 2020 flow diagram used in the present systematic review. A total of 7425 records were initially identified. After screening 5681 articles by title and abstract, 84 articles were retrieved for eligibility analyses through a full-text reading. Of these, 33 articles were finally selected [17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49]. Each section may be divided by subheadings. It should provide a concise and precise description of the experimental results, their interpretation, as well as the experimental conclusions that can be drawn.
Table 1 describes the main characteristics of all cohort studies selected. The population sample sizes ranged between 323 and 121,700 participants; 24 studies were conducted on both sexes, 4 only in men, and 5 only in women; 8 studies recruited participants in the USA, 7 in Finland, 1 in Australia, 4 in France, 6 in the United Kingdon, 1 in Israel, 1 in Sweden, 3 from China, and 1 in the Netherlands; participants were followed up between 10 and 30 years; the 11 definitions of frailty used across the cohort studies were Fried phenotype [2] (15 studies), Modified Fried phenotype (6 studies), FRAIL scale—Abellan van Kan et al. [50] (1 study), FRAIL scale—Morley et al. [51] (4 studies), Modified FRAIL scale—Morley et al. (1 study), Frailty index—Mitnitski et al. [3] (2 studies), Hospital Frailty Risk Score (HFRS)—Gilbert et al. [52] (1 study), Frailty phenotype—Kucharska-Newton et al. [53] (1 study), Frailty phenotype—Strawbridge et al. [54] (1 study), and Frailty index—Searle et al. [55] (1 study). The prevalence of frailty ranged between 2 and 61%.
The exposure variables of the 33 articles selected were dietary inflammatory index in adulthood (1 study), blood inflammatory markers in adulthood (two studies), alcohol consumption in adulthood (three studies), sitting time in adulthood (one study), multicomponent healthy heart score in adulthood (one study), overweight/obesity or higher BMI in adulthood (four studies), neighborhood-social deprivation in childhood (one study), cardiovascular risk scores in adulthood (two studies), physical inactivity in adulthood (five studies), asthma in adulthood (one study), anemia in adulthood (one study), diabetes in adulthood (one study), high liver enzymes (one study), dietary clusters (pasta or biscuits plus snacking) in adulthood (one study), birth body composition (BMI, weight, length) (one study), children of separated parents in childhood (one study), fruit and vegetable consumption in adulthood (three studies), smoking status in adulthood (two studies), nonsteroidal anti-inflammatory drugs (NSAID) use (one study), neighborhood quality in adulthood (one study), education level achievement (three studies), paternal education (one study), occupation or employment level in adulthood (two studies), low literacy in adulthood (one study), low income in adulthood (one study), malnutrition in adulthood (one study), depression in adulthood (one study), forced expiratory volume or HDL cholesterol or hypertension (one study), sugar-sweetened beverages or artificial sweetened beverage or orange juices or non-orange juices (one study), red meat in adulthood (one study), pain during walking in adulthood (one study), subjective social status (one study), health-related quality of life (one study), and social vulnerability index in adulthood (one study).
Table 2 shows the analytical approaches used to account for confounding due to pre-existing diseases in 33 studies examining the association between risk factors and frailty. In 10 of them, authors omitted the inclusion of any type of disease as a covariate in their fully adjusted models; only 2 studies excluded all participants with diseases in main analyses; and another 2 used sensitivity analyses.
Table 3 shows the scored risk of confounding due to pre-existing diseases in the 33 studies selected. The final score takes into account whether studies included participants younger than 70 years at baseline or not, whether studies excluded participants with diseases/conditions at baseline, and whether studies adjusted for diseases/conditions in the fully adjusted model. A total of 16 studies scored a low risk of confounding due to pre-existing diseases (0 or 1 point) and the rest a high risk of confounding (2 or 3 points).
Table S2 shows whether authors included physical activity or nutritional factors (energy intake, quality nutritional indexes, sugar-sweetened beverages, and red meat) as covariates in their regression models. In 20 studies, authors omitted both physical activity and nutritional factors as covariates in their statistical analyses.

4. Discussion

The goal of this systematic review was to identify early-life and middle-life risk factors (any exposure variable) associated with frailty. We found evidence that maintaining a normal weight in adulthood, being physically active, not smoking tobacco, refraining from ultra-processed food and beverages, and avoiding excessive alcohol intake may decrease the risk of frailty several decades later. These findings may have important implications for elderly populations because, in theory, most cases of frailty might be prevented if populations remain healthy before older age. For example, staying physically active in adulthood was robustly associated with a lower future risk of frailty [32]. The physiological mechanisms underlying the positive influence of physical activity on frailty prevention have been comprehensively reviewed elsewhere [5]. On the other hand, the regular consumption of fruits and vegetables and a low consumption of SSBs or ASBs were also associated with a lower risk of becoming frail [46]. Therefore, it seems unquestionable that diet and physical activity have a key role in preventing the future risk of frailty. In support of this, we found that obesity [21], diabetes [26], or having worse cardiovascular risk scores [27] or blood inflammatory markers [40] were equally associated with a higher risk of frailty. The mechanisms by which high ultra-processed foods and beverages promote obesity, diabetes, or cardiovascular disease are complex and only partially known nowadays. High ultra-processed foods and beverages may result in unique patterns of gut–brain signals during digestion processes, as they are absorbed more proximally in the gut compared with natural foods and beverages. Altered absorption of nutrients and a low amount of fiber in the diet may play important disruptions in appetite control, leading to a long-term positive energy balance [56].
Nonetheless, a second goal of our review was to evaluate whether authors included appropriate analytical methods to deal with confounding due to pre-existing diseases and we found serious deficiencies in this matter. For example, many (half of the studies selected) epidemiological studies of risk factors of frailty were at high risk of confounding due to pre-existing diseases. Another source of concern was the observation that the majority of studies did not adjust their effect estimates by important confounders such as physical activity or nutritional factors. The framing that frailty is a direct consequence of the normal aging process should be approached with caution, as we also find evidence that frailty was associated with worse socioeconomic markers (income, education, and employment). So far, the mechanisms linking socioeconomic factors with frailty remain unexplored, and multiple factors may be involved (beyond the proven benefits of physical activity or healthy diets). Although the best way to define frailty is still debated among scientists [51], future studies should adopt (at least) the most common definition of frailty (Fried phenotype) to allow a future synthesis of the scientific evidence [57].
To move the field forward, it is important to acknowledge that well-powered randomized clinical trials, although the gold standard of scientific inquiry, are limited in their ability to add valuable insights for prevention because it is unfeasible to test human interventions with a duration of 10 years or more. To illustrate how clinical trials in the elderly do not always offer important insights about how to prevent frailty, see reference [58], where a complex intervention that combined a nutrition plus physical activity intervention over 2 years was ineffective in reducing frailty in older adults. Although it could be argued that the design of interventions was not optimal (for example, short duration or the physical activity intervention only included 1 h per week of strength plus balance instead of exercise programs of aerobic activities based on physical activity recommendations for health in adults), the authors stressed that their interventions mirrored the real world (good external validity). Consequently, we think that future studies on this topic should rely on well-designed cohort studies with valid methodologies of assessment of exposure variables and robust statistical analysis (including sensitivity analyses). Our systematic review examines, for the first time, what modifiable factors may determine a higher long-term risk of frailty (life course epidemiology) and evaluates the risk of confounding due to pre-existing diseases. Despite employing a comprehensive search strategy, we found very few studies evaluating the same exposure variable, which precluded our ability to perform additional meta-analyses. Therefore, we acknowledge that progress in this field of study is still limited. Nonetheless, facilitating the adoption of cardiovascular healthy behaviors in the general population seems a promising strategy of intervention to prevent frailty.

5. Conclusions

Maintaining a normal weight in adulthood, being physically active, not smoking tobacco, refraining from ultra-processed food and beverages, and avoiding excessive alcohol intake may decrease the risk of frailty several decades later. The framing that frailty is a direct consequence of the normal aging process should be viewed with caution, as we found clear evidence that more vulnerable socioeconomic groups are more likely to become frail.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/healthcare12010022/s1, Table S1: Search strategy of the systematic review of cohort studies examining associations of risk factors with frailty; Table S2: Physical activity and nutritional variables as covariates in 33 studies examining the association between risk factors and frailty.

Author Contributions

Conceptualization, J.P.R.-L.; methodology, J.P.R.-L. and L.F.M.R.; software, A.S.; data extraction, J.P.R.-L. and A.B.; writing and editing, all authors. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created in this systematic review. Readers may contact with corresponding author to clarify any doubt regarding the methodology used.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chen, R.; Wang, Y.; Zhang, S.; Bulloch, G.; Zhang, J.; Liao, H.; Shang, X.; Clark, M.; Peng, Q.; Ge, Z.; et al. Biomarkers of ageing: Current state-of-art, challenges, and opportunities. MedComm-Future Med. 2023, 2, e50. [Google Scholar] [CrossRef]
  2. Fried, L.P.; Tangen, C.M.; Walston, J.; Newman, A.B.; Hirsch, C.; Gottdiener, J. Frailty in older adults: Evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56, 146–156. [Google Scholar] [CrossRef]
  3. Mitnitski, A.B.; Mogilner, A.J.; Rockwood, K. Accumulation of deficits as a proxy measure of aging. Sci. World J. 2001, 1, 323–336. [Google Scholar] [CrossRef]
  4. O’Caoimj, R.; Sezgin, D.; O’Donovan, M.R.; William Molloy, D.; Clegg, A.; Rockwood, M.R.; Liew, A. Prevalence of frailty in 62 countries across the world: A systematic review and meta-analysis of population-level studies. Age Ageing 2021, 50, 96–104. [Google Scholar] [CrossRef]
  5. Taylor, J.A.; Greenhaff, P.L.; Bartlett, D.B.; Jackson, T.A.; Duggal, N.A.; Lord, J.M. A multisystem physiological perspective of human frailty and its modulation by physical activity. Physiol. Rev. 2023, 103, 1137–1191. [Google Scholar] [CrossRef]
  6. Kojima, G. Frailty as a predictor of future falls among community-dwelling older people: A systematic review and meta-analysis. J. Am. Med. Dir. Assoc. 2015, 16, 1027–1033. [Google Scholar] [CrossRef]
  7. Ensrud, K.E.; Ewing, S.K.; Taylor, B.C.; Fink, H.A.; Stone, K.L.; Cauley, J.A.; Tracy, J.K.; Hochberg, M.C.; Rodondi, N.; Cawthon, P.M.; et al. Frailty and risk of falls, fracture, and mortality in older women: The study of osteoporotic fractures. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62, 744–751. [Google Scholar] [CrossRef]
  8. Kojima, G. Frailty as a predictor of hospitalization among community-dwelling older people: A systematic review and meta-analysis. J. Epidemiol. Community Health 2016, 70, 722–729. [Google Scholar] [CrossRef]
  9. Kojima, G. Frailty as a predictor of nursing home placement among community-dwelling older adults: A systematic review and meta-analysis. J. Geriatr. Phys. Ther. 2018, 41, 42–48. [Google Scholar] [CrossRef]
  10. Shamliyan, T.; Talley, K.M.; Ramakrishnan, R.; Kane, R.L. Association of frailty with survival: A systematic literature review. Ageing Res. Rev. 2013, 12, 719–736. [Google Scholar] [CrossRef]
  11. Wang, X.; Hu, J.; Wu, D. Risk factors for frailty in older adults. Medicine 2022, 101, e30169. [Google Scholar] [CrossRef] [PubMed]
  12. Shultz, J.M.; Sullivan, L.M.; Galea, S. Public Health: An Introduction to the Science and Practice of Population Health, 1st ed.; Springer Publishing Company: New York, NY, USA, 2021; pp. 182–185. [Google Scholar]
  13. Hernan, M.A.; Robins, J.M. Causal Inference: What If? Chapman & Hall/CRC: Boca Raton, FL, USA, 2020. [Google Scholar]
  14. Rezende, L.F.M.; Lee, D.H.; Ferrari, G.; Giovannucci, E. Confounding due to pre-existing diseases in epidemiological studies on sedentary behavior and all-cause mortality: A meta-epidemiological study. Ann. Epidemiol. 2020, 52, 7–14. [Google Scholar] [CrossRef] [PubMed]
  15. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef] [PubMed]
  16. Savitz, D.A.; Wellenius, G.A.; Trikalinos, T.A. The problem with mechanistic risk of bias assessments in evidence synthesis of observational studies and a practical alternative: Assessing the impact of specific sources of potential bias. Am. J. Epidemiol. 2019, 188, 1581e5. [Google Scholar] [CrossRef] [PubMed]
  17. Millar, C.L.; Dufour, A.B.; Shivappa, N.; Habtemariam, D.; Murabito, J.M.; Benjamin, E.J.; Hebert, J.R.; Kiel, D.P.; Hannan, M.T.; Sahni, S. A proinflammatory diet is associated with increased odds of frailty after 12-year follow-up in a cohort of adults. Am. J. Clin. Nutr. 2022, 115, 334–343. [Google Scholar] [CrossRef] [PubMed]
  18. Strandberg, A.Y.; Trygg, T.; Pitkälä, K.H.; Strandberg, T.E. Alcohol consumption in midlife and old age and risk of frailty: Alcohol paradox in a 30-year follow-up study. Age Ageing 2018, 47, 248–254. [Google Scholar] [CrossRef] [PubMed]
  19. Susanto, M.; Hubbard, R.E.; Gardiner, P.A. Association of 12-year trajectories of sitting time with frailty in middle-aged women. Am. J. Epidemiol. 2018, 187, 2387–2396. [Google Scholar] [CrossRef] [PubMed]
  20. Sotos-Prieto, M.; Struijk, E.A.; Fung, T.T.; Rimm, E.B.; Rodriguez-Artalejo, F.; Willett, W.C.; Hu, F.B.; Lopez-Garcia, E. Association between a lifestyle-based healthy heart score and risk of frailty in older women: A cohort study. Age Ageing 2022, 51, afab268. [Google Scholar] [CrossRef]
  21. Landré, B.; Czernichow, S.; Goldberg, M.; Zins, M.; Ankri, J.; Herr, M. Association between life-course obesity and frailty in older adults: Findings in the GAZEL cohort. Obesity 2020, 28, 388–396. [Google Scholar] [CrossRef]
  22. Baranyi, G.; Welstead, M.; Corley, J.; Deary, I.J.; Muniz-Terrera, G.; Redmond, P.; Shortt, N.; Taylor, A.M.; Ward Thompson, C.; Cox, S.R.; et al. Association of life-course neighborhood deprivation with frailty and frailty progression from ages 70 to 82 years in the Lothian birth cohort 1936. Am. J. Epidemiol. 2022, 191, 1856–1866. [Google Scholar] [CrossRef]
  23. Strandberg, T.E.; Sirola, J.; Pitkälä, K.H.; Tilvis, R.S.; Strandberg, A.Y.; Stenholm, S. Association of midlife obesity and cardiovascular risk with old age frailty: A 26-year follow-up of initially healthy men. Int. J. Obes. 2012, 36, 1153–1157. [Google Scholar] [CrossRef]
  24. Kheifets, M.; Goshen, A.; Goldbourt, U.; Witberg, G.; Eisen, A.; Kornowski, R.; Gerber, Y. Association of socioeconomic status measures with physical activity and subsequent frailty in older adults. BMC Geriatr. 2022, 22, 439. [Google Scholar] [CrossRef]
  25. Landré, B.; Nadif, R.; Goldberg, M.; Gourmelen, J.; Zins, M.; Ankri, J.; Herr, M. Asthma is associated with frailty among community-dwelling adults: The GAZEL cohort. BMJ Open Respir. Res. 2020, 7, e000526. [Google Scholar] [CrossRef]
  26. Wennberg, A.M.; Ding, M.; Ebeling, M.; Hammar, N.; Modig, K. Blood-based biomarkers and long-term risk of frailty-experience from the Swedish AMORIS cohort. J. Gerontol. A Biol. Sci. Med. Sci. 2021, 76, 1643–1652. [Google Scholar] [CrossRef]
  27. Bouillon, K.; Batty, G.D.; Hamer, M.; Sabia, S.; Shipley, M.J.; Britton, A.; Singh-Manoux, A.; Kivimäki, M. Cardiovascular disease risk scores in identifying future frailty: The Whitehall II prospective cohort study. Heart 2013, 99, 737–742. [Google Scholar] [CrossRef]
  28. Pilleron, S.; Ajana, S.; Jutand, M.A.; Helmer, C.; Dartigues, J.F.; Samieri, C.; Féart, C. Dietary patterns and 12-year risk of frailty: Results from the three-city Bordeaux study. J. Am. Med. Dir. Assoc. 2017, 18, 169–175. [Google Scholar] [CrossRef]
  29. Haapanen, M.J.; Perälä, M.M.; Salonen, M.K.; Kajantie, E.; Simonen, M.; Pohjolainen, P.; Eriksson, J.G.; von Bonsdorff, M.B. Early life determinants of frailty in old age: The Helsinki Birth Cohort Study. Age Ageing 2018, 47, 569–575. [Google Scholar] [CrossRef]
  30. Haapanen, M.J.; Perälä, M.M.; Salonen, M.K.; Kajantie, E.; Simonen, M.; Pohjolainen, P.; Pesonen, A.K.; Räikkönen, K.; Eriksson, J.G.; von Bonsdorff, M.B. Early life stress and frailty in old age: The Helsinki birth cohort study. BMC Geriatr. 2018, 18, 179. [Google Scholar] [CrossRef]
  31. Fung, T.T.; Struijk, E.A.; Rodriguez-Artalejo, F.; Willett, W.C.; Lopez-Garcia, E. Fruit and vegetable intake and risk of frailty in women 60 years old or older. Am. J. Clin. Nutr. 2020, 112, 1540–1546. [Google Scholar] [CrossRef]
  32. Gil-Salcedo, A.; Dugravot, A.; Fayosse, A.; Dumurgier, J.; Bouillon, K.; Schnitzler, A.; Kivimäki, M.; Singh-Manoux, A.; Sabia, S. Healthy behaviors at age 50 years and frailty at older ages in a 20-year follow-up of the UK Whitehall II cohort: A longitudinal study. PLoS Med. 2020, 17, e1003147. [Google Scholar] [CrossRef]
  33. Haapanen, M.J.; Perälä, M.M.; Osmond, C.; Salonen, M.K.; Kajantie, E.; Rantanen, T.; Simonen, M.; Pohjolainen, P.; Eriksson, J.G.; von Bonsdorff, M.B. Infant and childhood growth and frailty in old age: The Helsinki birth cohort study. Aging Clin. Exp. Res. 2019, 31, 717–721. [Google Scholar] [CrossRef]
  34. Orkaby, A.R.; Ward, R.; Chen, J.; Shanbhag, A.; Sesso, H.D.; Gaziano, J.M.; Djousse, L.; Driver, J.A. Influence of long-term nonaspirin NSAID use on risk of frailty in men ≥60 years: The Physicians’ Health study. J. Gerontol. A Biol. Sci. Med. Sci. 2022, 77, 1048–1054. [Google Scholar] [CrossRef]
  35. Savela, S.L.; Koistinen, P.; Stenholm, S.; Tilvis, R.S.; Strandberg, A.Y.; Pitkälä, K.H.; Salomaa, V.V.; Strandberg, T.E. Leisure-time physical activity in midlife is related to old age frailty. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 68, 1433–1438. [Google Scholar] [CrossRef]
  36. Li, Y.; Xue, Q.L.; Odden, M.C.; Chen, X.; Wu, C. Linking early life risk factors to frailty in old age: Evidence from the China health and retirement longitudinal study. Age Ageing 2020, 49, 208–217. [Google Scholar] [CrossRef]
  37. Yeung, S.S.Y.; Chan, R.S.M.; Kwok, T.; Lee, J.S.W.; Woo, J. Malnutrition according to GLIM criteria and adverse outcomes in community-dwelling Chinese older adults: A prospective analysis. J. Am. Med. Dir. Assoc. 2021, 22, 1953–1959. [Google Scholar] [CrossRef]
  38. Brunner, E.J.; Shipley, M.J.; Ahmadi-Abhari, S.; Valencia Hernandez, C.; Abell, J.G.; Singh-Manoux, A.; Kawachi, I.; Kivimaki, M. Midlife contributors to socioeconomic differences in frailty during later life: A prospective cohort study. Lancet Public Health 2018, 3, e313–e322. [Google Scholar] [CrossRef]
  39. Stenholm, S.; Strandberg, T.E.; Pitkälä, K.; Sainio, P.; Heliövaara, M.; Koskinen, S. Midlife obesity and risk of frailty in old age during a 22-year follow-up in men and women: The mini-Finland follow-up survey. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69, 73–78. [Google Scholar] [CrossRef]
  40. Walker, K.A.; Walston, J.; Gottesman, R.F.; Kucharska-Newton, A.; Palta, P.; Windham, B.G. Midlife systemic inflammation is associated with frailty in later life: The ARIC Study. J. Gerontol. A Biol. Sci. Med. Sci. 2019, 74, 343–349. [Google Scholar] [CrossRef]
  41. Sodhi, J.K.; Karmarkar, A.; Raji, M.; Markides, K.S.; Ottenbacher, K.J.; Al Snih, S. Pain as a predictor of frailty over time among older Mexican Americans. Pain 2020, 161, 109–113. [Google Scholar] [CrossRef]
  42. Struijk, E.A.; Fung, T.T.; Sotos-Prieto, M.; Rodriguez-Artalejo, F.; Willett, W.C.; Hu, F.B.; Lopez-Garcia, E. Red meat consumption and risk of frailty in older women. J. Cachexia Sarcopenia Muscle 2022, 13, 210–219. [Google Scholar] [CrossRef]
  43. Dugravot, A.; Fayosse, A.; Dumurgier, J.; Bouillon, K.; Rayana, T.B.; Schnitzler, A.; Kivimaki, M.; Sabia, S.; Singh-Manoux, A. Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: A 24-year follow-up of the Whitehall II cohort study. Lancet Public. Health 2020, 5, e42–e50. [Google Scholar] [CrossRef]
  44. Hoogendijk, E.O.; Heymans, M.W.; Deeg, D.J.H.; Huisman, M. Socioeconomic inequalities in frailty among older adults: Results from a 10-year longitudinal study in the Netherlands. Gerontology 2018, 64, 157–164. [Google Scholar] [CrossRef]
  45. Yu, R.; Tong, C.; Leung, J.; Woo, J. Socioeconomic inequalities in frailty in Hong Kong, China: A 14-year longitudinal cohort study. Int. J. Environ. Res. Public. Health 2020, 17, 1301. [Google Scholar] [CrossRef]
  46. Struijk, E.A.; Rodríguez-Artalejo, F.; Fung, T.T.; Willett, W.C.; Hu, F.B.; Lopez-Garcia, E. Sweetened beverages and risk of frailty among older women in the Nurses’ Health Study: A cohort study. PLoS Med. 2020, 17, e1003453. [Google Scholar] [CrossRef]
  47. Landré, B.; Ben Hassen, C.; Kivimaki, M.; Bloomberg, M.; Dugravot, A.; Schniztler, A.; Sabia, S.; Singh-Manoux, A. Trajectories of physical and mental functioning over 25 years before onset of frailty: Results from the Whitehall II cohort study. J. Cachexia Sarcopenia Muscle 2023, 14, 288–297. [Google Scholar] [CrossRef]
  48. Amieva, H.; Ouvrard-Brouillou, C.; Dartigues, J.F.; Pérès, K.; Tabue Teguo, M.; Avila-Funes, A. Social vulnerability predicts frailty: Towards a distinction between fragility and frailty? J. Frailty Aging 2022, 11, 318–323. [Google Scholar] [CrossRef]
  49. Niederstrasser, N.G.; Rogers, N.T.; Bandelow, S. Determinants of frailty development and progression using a multidimensional frailty index: Evidence from the English Longitudinal Study of Ageing. PLoS ONE 2019, 14, e0223799. [Google Scholar] [CrossRef]
  50. Abellan van Kan, G.; Rolland, Y.; Bergman, H.; The, I.A.N.A. Task Force on frailty assessment of older people in clinical practice. J. Nutr. Health Aging 2008, 12, 29–37. [Google Scholar] [CrossRef]
  51. Morley, J.E.; Malmstrom, T.K.; Miller, D.K. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J. Nutr. Health Aging 2012, 16, 601–608. [Google Scholar] [CrossRef]
  52. Gilbert, T.; Neuburger, J.; Kraindler, J.; Keeble, E.; Smith, P.; Ariti, C. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: An observational study. Lancet 2018, 391, 1775–1782. [Google Scholar] [CrossRef]
  53. Kucharska-Newton, A.M.; Palta, P.; Burgard, S.; Griswold, M.E.; Lund, J.L.; Capistrant, B.D.; Kritchevsky, S.B.; Bandeen-Roche, K.; Windham, B.G. Operationalizing frailty in the Atherosclerosis Risk in Communities Study Cohort. J. Gerontol. A Biol. Sci. Med. Sci. 2017, 72, 382–388. [Google Scholar] [CrossRef] [PubMed]
  54. Strawbridge, W.J.; Shema, S.J.; Balfour, J.L.; Higby, H.R.; Kaplan, G.A. Antecedents of frailty over three decades in an older cohort. J. Gerontol. B Psychol. Sci. Soc. Sci. 1998, 53, S9–S16. [Google Scholar] [CrossRef] [PubMed]
  55. Searle, S.D.; Mitnitski, A.; Gahbauer, E.A.; Gill, T.M.; Rockwood, K. A standard procedure for creating a frailty index. BMC Geriatr 2008, 8, 24. [Google Scholar] [CrossRef] [PubMed]
  56. Hall, K.D. From dearth to excess: The rise of obesity in an ultra-processed food system. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2023, 378, 20220214. [Google Scholar] [CrossRef]
  57. Hoogendijk, E.O.; Afilalo, J.; Ensrud, K.E.; Kowal, P.; Onder, G.; Fried, L.P. Frailty: Implications for clinical practice and public health. Lancet 2019, 394, 1365–1375. [Google Scholar] [CrossRef]
  58. Teh, R.; Barnett, D.; Edlin, R.; Kerse, N.; Waters, D.L.; Hale, L.; Tay, E.; Leilua, E.; Pillai, A. Effectiveness of a complex intervention of group based nutrition and physical activity to prevent frailty in pre-frail older adults (SUPER): A randomised controlled trial. Lancet Healthy Longev. 2022, 3, 519–530. [Google Scholar] [CrossRef]
Figure 1. PRISMA 2020 flow diagram showing 33 cohort studies (with at least 10 years of follow-up) of early-life and middle-life risk factors of frailty.
Figure 1. PRISMA 2020 flow diagram showing 33 cohort studies (with at least 10 years of follow-up) of early-life and middle-life risk factors of frailty.
Healthcare 12 00022 g001
Table 1. Main characteristics of 33 cohort studies included, examining associations between any exposure variable and risk of frailty.
Table 1. Main characteristics of 33 cohort studies included, examining associations between any exposure variable and risk of frailty.
First Author and
Year of Publication
Population
(Total Sample, Age at Baseline, Sex, Country)
Follow-Up
(Mean or Median)
Frailty Definition/
Prevalence of Frailty at Follow-Up
Exposure Variable/Effect Size-Fully Adjusted Model:
OR, RR, HR, Beta (95% CI)/Sensitivity Analyses
Covariates of the Fully Adjusted Model
Millar et al. (2022) [17]n = 1701
(55.4% women)
Mean 58 years
Both sexes
USA
12 yearsFried frailty phenotype
13%
Energy-adjusted dietary inflammatory index (E-DII)
Per 1-unit increase E-DII:
OR = 1.16 (1.07, 1.25)
Quartile 4 versus 1:
OR = 2.22 (1.37, 3.60)
No sensitivity analyses
Age, sex, energy intake, smoking, depressive symptoms, diabetes, cardiovascular disease, and cancer
Strandberg et al. (2018) [18]n = 2360
(92% without chronic diseases or medications at baseline)
Mean 49 years
Men
Finland
30 yearsFried frailty phenotype
10%
Alcohol consumption
>196 g per week versus 1–98 g per week
OR = 1.61 (1.01, 2.56)
No sensitivity analyses
Age, BMI, smoking
Susanto et al. (2018) [19]n = 5462
Median 52 years
Women
Australia
12 yearsFRAIL scale (Abellan van Kan et al.)
7%
Increasing sitting time versus medium sitting time
OR = 1.29 (1.03, 1.61)
High sitting time versus medium sitting time
OR = 1.42 (1.10, 1.84)
No sensitivity analyses
Relationship status, education, body mass index, smoking status, alcohol consumption, physical activity, employment, and the presence of arthritis, depression, or hypertension
Sotos-Prieto et al. (2022) [20]n = 121,700
Range 30–55 years
Women
USA
22 years FRAIL scale (Morley et al.)
9%
Healthy Heart Score based on smoking, alcohol intake, BMI, physical activity and a diet score that includes five components, namely cereal fibre intake, and consumption of fruits/vegetables, nuts, sugary drinks, and red and processed meats
Quintile 5 versus Quintile 1
OR = 5.48 (5.01, 6.00)
Excluding individuals with CVD, cancer or diabetes (n = 9086), the associations remained similar. Slight attenuation in results from 6-, 10-, and 14-year lag analyses
Age, energy intake, and medication use (aspirin, postmenopausal hormone replacement therapy, diuretics, β-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, other blood pressure medication, statins and other cholesterol-lowering drugs, insulin, and oral hypoglycemic medication)
Landré et al. (2020) [21]n = 11,784
(35% Women)
Range 61–76 years
Both sexes
France
26 yearsFried frailty phenotype (modified)
Men 5%
Women 10%
Overweight versus normal BMI
Women
OR = 1.79 (1.23, 2.60)
Men
OR = 1.11 (0.83, 1.48)
Obesity versus normal BMI
Women
OR = 8.18 (5.36, 12.50)
Men
OR = 4.29 (3.07, 6.01)
No sensitivity analyses
Men
Age, education, marital status, tobacco and alcohol consumption, diabetes, joint pain, psychological problems, cancer, and cardiovascular disease events
Women
Age, education, marital status, tobacco and alcohol consumption, diabetes, joint pain, psychological problems, and cancer events
Baranyi et al. (2022) [22]n = 323
(35% Women)
Mean 70 years
Both sexes
UK
Retrospective (early life risk factors)Frailty index (Mitnitski et al.)
Unreported prevalence
Neighborhood social deprivation in childhood (reference category not reported)
Men
OR = 2.35 (1.40, 4.40)
No sensitivity analyses
Covariates unreported
Strandberg et al. (2012) [23]n = 1815
Mean 47 years
Men
Finland
26 yearsFried frailty phenotype
(Modified)
10%
Overweight versus normal BMI
OR = 2.06 (1.21, 3.52)
Obesity versus normal BMI
OR = 5.41 (1.94, 15.10)
Composite risk score for Coronary Artery Disease (CAD) per 1-unit increase
OR = 1.97 (1.63, 2.39)
No sensitivity analyses
Age, weight gain, BMI, smoking, systolic blood pressure, resting heart rate, trigycerides, 1 h post load blood glucose, and composite risk score for CAD
Kheifets et al. (2022) [24]n = 1799
(53% women)
Mean age 75
Both sexes
Israel
12–14 yearsFried frailty phenotype
14%
Physically inactive versus active
OR = 1.71 (0.90, 2.24)
No sensitivity analyses
Age, sex, socioeconomic status, heart attack, cardiac insufficiency, other heart disease, stroke, cataract, glaucoma, chronic renal failure, cancer, Alzheimer’s disease, Parkinson’s disease, asthma, other lung disease, diabetes, osteoporosis, dyslipidemia, and hypertension
Landré et al. (2020) [25]n = 12,345
(27% women)
Mean age 70
Both sexes
France
26 yearsFried frailty phenotype
(Modified)
6%
Asthma (at least one report) versus not having asthma
OR = 1.50 (1.15, 1.98)
No sensitivity analyses
Age, sex, BMI, education, marital status, tobacco consumption, diabetes, joint pain, cancer, cardiac diseases, and mental status
Wennberg et al. (2021) [26]n = 19,341
(61% women)
Mean age 72
Both sexes
Sweeden
12 yearsHospital Frailty Risk Score (HFRS) Gilbert et al.
27%
Anemia versus normal biomarkers
OR = 1.54 (1.38, 1.73)
Diabetes versus normal biomarkers
OR = 1.59 (1.43, 1.77)
Liver enzymes, high versus normal
OR = 1.14 (1.01, 1.30)
Frailty events during the first year were censored
Age and sex
Bouillon et al. (2013) [27]n = 3895
(27% women)
45–69 years
Both sexes
UK
10 yearsFried frailty phenotype
3%
Per 1 Standard Deviation increase
Framingham CVD risk score
OR = 1.42 (1.23, 1.62)
Framingham CHD risk score
OR = 1.38 (1.20, 1.59)
Framingham stroke risk score
OR = 1.35 (1.21, 1.51)
SCORE (CVD risk score)
OR = 1.36 (1.18, 1.56)
No sensitivity analyses
Age, sex, and antihypertensive treatment
Pilleron et al. (2017) [28]n = 972
(65% women)
Mean 73 years
Both sexes
France
12 yearsFried frailty phenotype
Men 2%
Women 4%
Dietary cluster Pasta
OR = 2.21 (1.11, 4.40)
Dietary cluster Biscuits and Snacking
OR = 1.81 (1.17, 2.81)
No sensitivity analyses
Marital status, education level, income, multimorbidity (hypertension, diabetes, hypercholesterolemia, angina, cardiac rhythm disorders, cardiac failure, arteritis, myocardial infarction, asthma, Parkinson disease, dyspnea, osteoporosis, and thyroid diseases), BMI, depressive symptomatology, and MMSE (Mini-Mental State Exam)
Haapanen et al. (2018) [29]n = 1078
(56% women)
Mean 71 years
Both sexes
Finland
Retrospective
(early life risk factors)
Fried frailty phenotype
Men 3%
Women 4%
Birth weight (1 kg increase)
RRR = 0.36 (0.15, 0.86)
Birth length (1 cm increase)
RRR = 0.77 (0.66, 0.94)
Birth BMI (1 unit increase)
RRR = 0.03 (0.001, 0.77)
No sensitivity analyses
Age, sex, gestational age, childhood and adulthood SES, adult BMI, smoking, and prevalence of diabetes or hypertension
Haapanen et al. (2018) [30]n = 972
(65% women)
Mean 71 years
Both sexes
Finland
Retrospective
(early life risk factors)
Fried frailty phenotype
Men 3%
Women 4%
Children separated in childhood versus non-separated (only in men)
RRR = 5.18 (1.16, 23.17)
No sensitivity analyses
Age, sex, gestational age, childhood and adulthood SES, adult BMI, smoking, and prevalence of diabetes or hypertension
Fung et al. (2020) [31]n = 78,366
≥60 years
Women
USA
20 yearsFRAIL scale (Morley et al.)
16%
Fruits and vegetables, at least 7 portions per day versus less than 3 servings
HR = 0.92 (0.85, 0.99)
While results for the 8 years lag analysis were weaker, a signal for an inverse association for fruits and vegetables was nevertheless observed
Age, smoking, energy intake, BMI, physical activity, postmenopausal hormone use, aspirin, antihypertensive or lipid lowering medications, diabetes medication, insulin, highest academic degree, census track income data, alcohol, and a modified Alternate Healthy Eating Index that does not include fruits and vegetables
Gil-Salcedo et al. (2020) [32]n = 6357
(29% women)
Mean 44 years
Both sexes
UK
20 yearsFried frailty phenotype
7%
Smoking status (never versus current)
HR = 0.68 (0.52, 0.89)
Alcohol consumption (moderate versus high)
HR = 0.76 (0.59, 0.98)
Physical activity (active versus inactive)
HR = 0.66 (0.48, 0.88)
Fruits and vegetables consumption (at least twice a day)
HR = 0.70 (0.53, 0.92)
All sensitivity analyses yielded results that were similar to those in the main analyses so that the risk of frailty decreased as the number of healthy behaviors at age 50 increased
Age, sex, ethnicity, marital status, and wave of inclusion, education and occupational position, number of morbidities at age 50 (diabetes, coronary heart disease, stroke, chronic obstructive pulmonary disease, depression, arthritis, cancer, hypertension, and obesity), and all other health behaviors examined
Haapanen et al. (2019) [33]n = 1078
(56% women)
Range 67–79 years
Both sexes
Finland
10 yearsFried frailty phenotype
Men 3%
Women 4%
Greater BMI gain (>17.5 kg/m2) during the period 2–11 yeas was associated with frailty
RRR age-adjusted = 2.36 (1.21, 4.63)
RRR fully adjusted = 2.07 (0.94, 4.56)
No sensitivity analyses
Age, childhood and adulthood SES, adulthood BMI, smoking, hypertension, and diabetes
Orkaby et al. (2022) [34]n = 12,101
≥60 years
Men
USA
11 yearsFrailty index (Mitnitski et al.)
20%
>60 days of daily Nonsteroideal anti-inflammatory drugs (NSAID) use versus no NSAID use
OR = 2.75 (2.29, 3.31)
No sensitivity analyses
Propensity score (using comorbidities related to NSAID use, smoking status, and alcohol consumption)
Savela et al. (2013) [35]n = 514
Mean 47 years
Men
Finland
26 yearsFried frailty phenotype
(Modified)
Unreported prevalence
High leisure time physical activity (>6 h per week) versus low (<2 h per week)
OR = 0.23 (0.08, 0.65)
No sensitivity analyses
Age, body mass index, smoking, blood pressure, alcohol consumption, and comorbidity index
Li et al. (2020) [36]n = 6806
(49% women)
Mean 69 years
Both sexes
China
10 yearsFried frailty phenotype
(Modified)
Unreported prevalence
Neighbourhood quality (highest versus lowest)
RR = 0.28 (0.15, 0.52)
Educational achievement
(at least high school versus illiterate)
RR = 0.23 (0.12, 0.44)
Paternal education
(Literate versus iliterate)
RR = 0.74 (0.57, 0.96)
Multiple imputation to deal with missing data
Age, sex, residence and marital status), activities of daily living (ADL) disability, and count of comorbidity
Yeung et al. (2021) [37]n = 3702
(51% women
Median 72 years
Both sexes
China
14 yearsFried frailty phenotype
Modified frail scale (Morley et al.)
11%
Malnutrition (GLIM criteria)
OR = 2.83 (1.47, 5.43) Fried
OR = 2.30 (1.06, 4.98) Frail scale
No sensitivity analyses
Age, sex, baseline BMI, current smoker, current drinker, live alone, being married, education level, subjective social status, dementia level, depressive symptoms, number of chronic diseases, and physical activity
Brunner et al. (2018) [38]n = 6233
(28% women)
Range 45–55 years
Both sexes
UK
18 years Fried frailty phenotype
4%
Men 3%
Women 6%
Current smoking status (versus never)
OR = 1.69 (1.27, 2.25)
High alcohol consumption (>14 units per week women, >21 units per week men; versus none)
OR = 1.54 (1.17, 2.04)
Occasional fruit and vegetable consumption (versus daily)
OR = 1.29 (1.05, 1.58)
Physical inactivity (versus active)
OR = 2.63 (2.06, 3.37)
Forced expiratory volume (<2.91 L versus >3.58 L)
OR = 1.90 (1.36, 2.65)
Obesity (versus normal weight)
OR = 3.52 (2.62, 4.72)
Depressive symptoms (versus none)
OR = 1.65 (1.33, 2.03)
Hypertension (versus normal blood pressure)
OR = 1.39 (1.10, 1.76)
HDL cholesterol (>1.59 mmol/L versus <1.25 mmol/L)
OR = 1.57 (1.16, 2.12)
Interleukin-6 concentration (>1.63 pg/mL versus <1.06 pg/mL)
OR = 2.23 (1.59, 3.13)
C-reactive protein concentration (>1.37 mg/L versus <0.56 mg/L)
OR = 1.94 (1.47, 2.56)
Employment grade level (per one unit lower)
OR = 1.49 (1.27, 1.75)
For employment grade level, sensitivity analysis showed physical activity but not body mass index contributed substantially to the attenuation when removed from the adjustment
Age, sex, time measured since fifth clinic, and ethnicity
Stenholm et al. (2014) [39]n = 1119
Mean 44 years
Both sexes
Finland
22 yearsFried frailty phenotype
5%
Obesity (versus normal weight)
OR = 5.02 (1.89, 13.33)
Including only robust participants at the baseline, obesity at baseline predicted development of frailty
Age, sex, education, smoking, alcohol use, physical activity, hypertension, coronary heart disease, other cardiovascular diseases, diabetes, osteoarthritis, inflammatory arthritis, and chronical mental disorder
Walker et al. (2019) [40]n = 5760
(58% women)
Range 50–54 years
Both sexes
USA
24 yearsFrailty phenotype by Kucharska-Newton et al.
7%
Inflammation score using fibrinogen, von Willebrand factor, and Factor VIII, and white blood cell count (per 1 standard devation increase)
OR = 1.39 (1.18, 1.65)
Findings were robust after excluding participants with high inflammatory markers, or clinical stroke or after accounting for bias related to selective attrition
Race, sex, education, socioeconomic status, cognitive status, arthritis, anti-inflammatory medication use, alcohol intake, smoking, and cholesterol markers
Sodhi et al. (2020) [41]n = 1545
(58% women)
≥67 years
Both sexes
USA
18 years Fried frailty phenotype
(Modified)
Unreported prevalence
Pain or discomfort during walking or standing (versus no pain or discomfort)
OR = 1.71 (1.41, 2.09)
No sensitivity analyses
Age, sex, marital status, education, comorbidity conditions (diabetes, heart attack, stroke, hypertension, cancer, hip fracture, and arthritis), BMI, mini mental state examination, depressive symptoms, and limitations of daily living
Struijk et al. (2022) [42]n = 85,871
≥60 years
Women
USA
22 yearsFRAIL scale (Morley et al.)
15%
Unprocessed red meat
(Per 1 serving per day)
OR = 1.08 (1.02, 1.15)
Processed red meat
(Per 1 serving per day)
OR = 1.26 (1.15, 1.39)
Physical activity was only in cluded as a covariate in a sensitivity analysis; results showed that including baseline physical activity only marginally lowered the estimates
Age, calendar time, census tract income, education, husband’s education, BMI, smoking status, alcohol intake, energy intake, medication use (aspirin, postmenopausal hormone therapy, diuretics, β-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, other blood pressure medication, statins and other cholesterol lowering drugs, insulin, or oral hypoglycaemic medication), consumption of fruits, vegetables, sugar-sweetened beverages, and mutually adjusted for other type of red meat
Dugravot et al. (2020) [43]n = 10,308
(33% women)
Range 35–55 years
Both sexes
UK
24 years (median)Fried frailty phenotype
27%
Low occupation (versus high)
HR = 2.08 (1.85, 2.33)
Low education (versus high)
HR = 1.08 (0.99, 1.18)
Low literacy (versus high)
HR = 1.05 (1.01, 1.19)
No sensitivity analyses
Sex, race, marital status, and birth cohort
Excluded subjects with multimorbidity before 50 years (two or more: diabetes, coronary heart disease, stroke, chronic obstructive pulmonary disease, depression, arthritis, cancer, dementia, and Parkinson’s disease)
Hoogendijk et al. (2018) [44]n = 1509
(52% women)
Mean 75 years
Both sexes
The Netherlands
10 yearsFrailty developed by Strawbridge et al.
29%
Low education (versus high)
OR = 1.30 (0.73, 2.31)
Lowest income (versus highest)
OR = 1.90 (1.20, 3.01)
Sensitivity analyses (imputation methods) to account for attrition caused by death during follow-up. Same conclusions about patterns of associations were drawn
Sex, year of birth, education, partner status, and income
Yu et al. (2020) [45]n = 694
(50% women)
≥65 years
Both sexes
China
14 years Fried frailty phenotype
30%
Subjective social status
Low (versus high)
OR = 2.34 (1.19, 4.60)
No sensitivity analyses
Age, sex, marital status, education, income, hypertension, diabetes, and stroke at baseline, smoking status, alcohol consumption, physical activity, mental health, and cognitive function
Struijk et al. (2020) [46]n = 71,935
Mean 63 years
Women
USA
22 years FRAIL scale (Morley et al.)
16%
Sugar sweetened beverages (2 or more servings per day versus never)
RR = 1.32 (1.10, 1.57)
Artificially sweetened beverages (2 or more servings per day versus never)
RR = 1.28 (1.17, 1.39)
Orange juice (1–2 servings per day versus never)
RR = 0.82 (0.76, 0.87)
Non-orange juices (1–2 servings per day versus never)
RR = 1.15 (1.03, 1.28)
Sensitivity analyses excluding participants with cardiovascular disease, diabetes, cancer, or overweight still showed a significant direct association
Age, calendar time, BMI, smoking status, alcohol intake, energy intake, physical activity, and medication use, overall diet quality, cancer, heart disease, and diabetes diagnosis
Landré et al. (2023) [47]n = 7044
(29% women)
Mean 50 years
Both sexes
UK
21 yearsFried frailty phenotype
7%
Health related quality of life
Physical component scores (versus worst quartile)
HR = 2.39 (1.85, 3.07)
Mental component scores (versus worst quartile)
HR = 1.49 (1.15, 1.93)
No sensitivity analyses
Sex, occupational position, marital status, ethnicity, and wave at age 50, alcohol consumption, smoking status, physical activity, fruit/vegetable consumption, BMI, and multimorbidity at age 50
Amieva et al. (2022) [48]n = 1531
(% women unreported)
Mean 72 years
Both sexes
France
27 yearsFrailty index (Searle et al.)
The cut-off of 0.2 points was used to discriminate the frail and robust participants
61%
Social vulnerability index (unreported whether exposure is a continuous or categorical variable)
HR = 2.34 (1.08, 5.07)
No sensitivity analyses
Age, sex, Instrumental Activies of Daily Living (IADL) disability, comorbidities, and Mini Mental State Examination (MMSE) score
Niederstrasser et al. (2019) [49]n = 7420
(55% women)
Mean 67 years
Both sexes
UK
12 yearsFrailty index (Searle et al.)
The cut-off higher than 0.25 points was used to discriminate the frail
34%
Vigorous physical activity (versus sedentary)
HR = 0.46 (0.36, 0.57)
No sensitivity analyses
Age, sex, waist circumference, BMI, income, education, gender, chair raises, smoking, pain, and loneliness
Table 2. Analytical approaches to account for confounding due to pre-existing diseases in 33 studies of risk factors and frailty.
Table 2. Analytical approaches to account for confounding due to pre-existing diseases in 33 studies of risk factors and frailty.
StudiesCovariates Accounted for Diseases in the Maximally Adjusted ModelMorbidity
CVDDiabetesCancerDepressionHypertensionArthritisCataractGlaucomaCKDAlzheimer Cognitive Function ParkinsonOsteoporosisLung DiseaseDyslipidemiaAsthmaThyroid Disease(Excluded at Baseline)
Millar et al., 2022 [17]
Strandberg et al., 2018 [18]
Susanto et al., 2018 [19]
Sotos-Prieto et al., 2022 [20]
Landré et al., 2020 [21]
Baranyi et al., 2022 [22]
Strandberg et al., 2012 [23]
Kheifets et al., 2022 [24]
Landré et al., 2020 [25]
Wennberg et al., 2021 [26]
Bouillon et al., 2013 [27]
Pilleron et al., 2016 [28]
Haapanen et al., 2018 [29]
Haapaanen et al., 2018 [30]
Fung et al., 2020 [31]
Gil-Salcedo et al., 2020 [32]
Haapaanen et al., 2018 [33]
Orkaby et al., 2022 [34]
Savela et al., 2013 [35]
Li et al., 2020 [36]
Yeung et al., 2020 [37]
Brunner et al., 2018 [38]
Stenhold et al., 2013 [39]
Walker et al., 2018 [40]
Sodhi et al., 2019 [41]
Struijk et al., 2022 [42]
Dugravot et al., 2019 [43]
Hoogendijk et al., 2017 [44]
Yu et al., 2020 [45]
Struijk et al., 2020 [46]
Niederstrasser et al., 2019 [49]
Landré et al., 2023 [47]
Amieva et al., 2022 [48]
Legend: None; adjusted in the model, excluded participants with morbidities in main analysis, excluded participants with morbidities in sensitivity analysis. CVD: cardiovascular disease; CPK: chronic kidney disease.
Table 3. Score risk of confounding due to pre-existing diseases in 33 studies examining the association between risk factors and frailty.
Table 3. Score risk of confounding due to pre-existing diseases in 33 studies examining the association between risk factors and frailty.
StudiesRisk of Confounding
Age
Lower 70 Years
Excluded
Diseases
Adjusted
Diseases
Score Risk of
Confounding
Millar et al., 2022 [17] 1
Strandberg et al., 2018 [18] 2
Susanto et al., 2018 [19] 1
Sotos-Prieto et al., 2022 [20] 1
Landré et al., 2020 [21] 2
Baranyi et al., 2022 [22] 3
Strandberg et al., 2012 [23] 1
Kheifets et al., 2022 [24] 2
Landré et al., 2020 [25] 2
Wennberg et al., 2021 [26] 3
Bouillon et al., 2013 [27] 1
Pilleron et al., 2016 [28] 2
Haapanen et al., 2018 [29] 2
Haapaanen et al., 2018 [30] 2
Fung et al., 2020 [31] 1
Gil-Salcedo et al., 2020 [32] 1
Haapaanen et al., 2018 [33] 2
Orkaby et al., 2022 [34] 2
Savela et al., 2013 [35] 1
Li et al., 2020 [36] 2
Yeung et al., 2020 [37] 1
Brunner et al., 2018 [38] 2
Stenhold et al., 2013 [39] 1
Walker et al., 2018 [40] 0
Sodhi et al., 2019 [41] 2
Struijk et al., 2022 [42] 1
Dugravot et al., 2019 [43] 1
Hoogendijk et al., 2017 [44] 3
Yu et al., 2020 [45] 1
Struijk et al., 2020 [46] 0
Landré et al., 2023 [47] 1
Amieva et al., 2022 [48] 2
Niederstrasser et al., 2019 [49] 2
Legend: red color: NO; green color: YES; high risk of confounding: score 2–3; low risk of confounding: score 0–1.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Barrera, A.; Rezende, L.F.M.; Sabag, A.; Keating, C.J.; Rey-Lopez, J.P. Understanding the Causes of Frailty Using a Life-Course Perspective: A Systematic Review. Healthcare 2024, 12, 22. https://doi.org/10.3390/healthcare12010022

AMA Style

Barrera A, Rezende LFM, Sabag A, Keating CJ, Rey-Lopez JP. Understanding the Causes of Frailty Using a Life-Course Perspective: A Systematic Review. Healthcare. 2024; 12(1):22. https://doi.org/10.3390/healthcare12010022

Chicago/Turabian Style

Barrera, Antonio, Leandro F. M. Rezende, Angelo Sabag, Christopher J. Keating, and Juan Pablo Rey-Lopez. 2024. "Understanding the Causes of Frailty Using a Life-Course Perspective: A Systematic Review" Healthcare 12, no. 1: 22. https://doi.org/10.3390/healthcare12010022

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop